South and Central America Cryoablation Market (2022-2033)

Surge in Chronic Disease Rates Observed

The South and Central America region is experiencing a noticeable rise in chronic illnesses that is shaping demand for advanced therapeutic solutions like cryoablation. Cardiovascular conditions such as arrhythmias and complex structural heart issues are increasingly seen in clinical practice across major markets like Brazil, Argentina, and Mexico. Leading cardiology centers in these countries are integrating minimally invasive procedures, including cryoablation, into their treatment pathways to address patient needs with reduced procedural risk and recovery time.

Cancer care in the region is also evolving, as oncology specialists look for localized treatment options that complement systemic therapies. Cryoablation is gaining interest in oncology clinics and interventional radiology departments for managing selected solid tumors, especially where preserving surrounding healthy tissue is a priority. Hospitals that serve metropolitan populations are incorporating cryoablation into their service mix to offer a broader range of options for patients who may not be ideal candidates for surgery.

In addition to heart and cancer care, aging populations and growing prevalence of metabolic conditions are increasing the overall procedural workload for tertiary care facilities. Providers are strengthening their chronic disease management programs and investing in technologies that can serve multiple specialties. As clinicians become more familiar with the clinical advantages of cryoablation, referrals for these procedures are rising, reinforcing the role of cryoablation in comprehensive treatment strategies across the region.

Exploring New Clinical Use Cases

Cryoablation in South and Central America is moving beyond its established applications and being explored for an expanding set of clinical indications. Pain management is emerging as an area of interest, with interventional pain clinics and multidisciplinary care teams evaluating cryoablation for targeted relief in patients with chronic or localized pain that has been difficult to manage with conventional therapies. This helps meet growing patient demand for minimally invasive options that can offer meaningful symptom control.

Structural and soft‑tissue procedures are another avenue where cryoablation is gaining traction. Hospitals with advanced imaging capabilities in cities such as São Paulo, Buenos Aires, and Santiago are incorporating cryoablation into care pathways for benign lesions and other localized conditions. These applications allow clinicians to treat challenging cases without resorting to more invasive surgery, aligning with broader institutional goals of reducing hospital stays and improving patient comfort.

Collaborations between device manufacturers and regional healthcare institutions are also supporting adoption in new clinical areas. Through training programs, procedural workshops, and shared clinical guidance, practitioners are building confidence in applying cryoablation techniques across a broader spectrum of indications—from pain and soft‑tissue interventions to emerging uses in specialty clinics. This collaborative ecosystem is strengthening cryoablation’s reputation as a flexible, versatile therapy throughout South and Central America.

The "South and Central America Cryoablation Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• South and Central America Cryoablation market size and forecast at regional and country levels for all market segments covered under the scope
• South and Central America Cryoablation market trends, as well as drivers, restraints, and opportunities
• South and Central America Cryoablation market analysis covering key trends, regional framework, major players, regulations, and recent developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the South and Central America Cryoablation market
• Detailed company profiles, including SWOT analysis

The geographical scope of the South and Central America cryoablation market report is divided into: Brazil, Argentina, Chile, Colombia, Peru, and the Rest of South and Central America. Brazil held the largest share in 2025.

Brazil dominates the South and Central America cryoablation market due to its advanced healthcare infrastructure, concentration of specialized hospitals, and focus on clinical innovation. Leading cardiac and oncology centers in major cities have integrated cryoablation into standard treatment protocols for complex arrhythmias and select tumor indications, supported by modern catheterization laboratories and imaging facilities. The country benefits from structured clinician training programs and collaboration with international medical device providers, which strengthens procedural expertise and confidence in cryoablation adoption. Multidisciplinary care teams, including electrophysiologists, interventional radiologists, and oncologists, ensure precise patient selection and optimal treatment outcomes. Patient awareness of minimally invasive therapies has increased demand, encouraging hospitals to expand service availability and invest in high-tech interventional suites. While regional disparities exist between urban and rural healthcare facilities, Brazil’s focus on healthcare modernization, technology adoption, and clinical excellence continues to reinforce its leadership in the South and Central America cryoablation market.

• The report includes qualitative and quantitative data in the South and Central America Cryoablation market across product type, application, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the South and Central America Cryoablation market.
• Chapter 3 focuses on the research methodology of the study.
• Chapter 4 includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the South and Central America Cryoablation market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the South and Central America Cryoablation market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 10 cover South and Central America Cryoablation market segments by product type, application, end user, and geography across Brazil, Argentina, Chile, Colombia, Peru, and the Rest of South and Central America. They cover the market revenue, forecast, and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the South and Central America Cryoablation market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The South and Central America cryoablation market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the South and Central America cryoablation market are:

• In April 2024, IceCure Medical Ltd. reported full‑year 2023 financial results noting that following regulatory approval in Brazil, commercial activities have commenced through its in‑country distributor and that procedures using the ProSense system are underway as part of its continued expansion into the Brazilian cryoablation market.
• In June 2022, IceCure Medical Ltd. announced that its distributor in Brazil, KTRFIOS Importaçao e Exportaçao Ltda., had submitted a regulatory filing to the Brazilian Health Regulatory Agency (ANVISA) for approval of the company’s ProSense cryoablation system across multiple oncological indications, marking a key step toward formal market entry in South America’s largest healthcare market.